Himalaya-The Podcast Player

4.8K Ratings
Open In App
title

ASHP Advantage's Engaging the Experts

ASHP Advantage

0
Followers
0
Plays
ASHP Advantage's Engaging the Experts

ASHP Advantage's Engaging the Experts

ASHP Advantage

0
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Podcast programs produced by ASHP Advantage for health care professionals.

Latest Episodes

Strategies for Prevention and Treatment of Recurrent C. difficile Infection

William Zellmer talks with Kevin Garey and Pablo Okhuysen about strategies for prevention and treatment of recurrent Clostridioides difficile infection.

21 MINAPR 29
Comments
Strategies for Prevention and Treatment of Recurrent C. difficile Infection

Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma

William Zellmer talks with Christine Walko and Shetal Patel about immune checkpoint inhibitors.

14 MINAPR 29
Comments
Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma

Revised USP Chapter 797 (Part 3): Practical Approaches to Attaining Compliance

In Part 3 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about practical approaches for attaining compliance.

17 MIN2019 JUL 23
Comments
Revised USP Chapter 797 (Part 3): Practical Approaches to Attaining Compliance

Revised USP Chapter 797 (Part 2): Getting Your Facility Ready

In Part 2 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about changes that may be needed to get your facility ready.

20 MIN2019 JUL 23
Comments
Revised USP Chapter 797 (Part 2): Getting Your Facility Ready

Revised USP Chapter <797> (Part 1): Overview of Changes

In Part 1 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about key changes to note.

15 MIN2019 JUL 23
Comments
Revised USP Chapter <797> (Part 1): Overview of Changes

Integrating Gene Therapies into Pharmacy Practice

William Zellmer talks with John Petrich and Michael Storey about gene therapies and considerations for integrating them into pharmacy practice.

19 MIN2019 JAN 19
Comments
Integrating Gene Therapies into Pharmacy Practice

Insourcing Sterile i.v. Compounding Service: Emory University Hospital Midtown Profile

Angela Cassano talks with Ryan Forrey about insourcing compounded sterile products and how he addressed the challenges faced at Emory University Hospital Midtown.

27 MIN2017 APR 27
Comments
Insourcing Sterile i.v. Compounding Service: Emory University Hospital Midtown Profile

Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2)

Part 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabetes and the roles for pharmacists in individualizing insulin therapy. This installment is produced by A S H P Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department ...

26 MIN2017 FEB 28
Comments
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2)

Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2)

Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department of Pharmacotherapy Washington State Unive...

21 MIN2017 FEB 28
Comments
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2)

Biosimilars: Current Status in the European Union and United States (Part 1 of 2)

In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical Pharmacy University of Michigan College of Pharmacy President, Hospital and Health System Services Visante, Inc. Ann Arbor, Michigan C.E. Credits: This activity is not eligible for continuing education credits.

18 MIN2016 FEB 6
Comments
Biosimilars: Current Status in the European Union and United States (Part 1 of 2)

Latest Episodes

Strategies for Prevention and Treatment of Recurrent C. difficile Infection

William Zellmer talks with Kevin Garey and Pablo Okhuysen about strategies for prevention and treatment of recurrent Clostridioides difficile infection.

21 MINAPR 29
Comments
Strategies for Prevention and Treatment of Recurrent C. difficile Infection

Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma

William Zellmer talks with Christine Walko and Shetal Patel about immune checkpoint inhibitors.

14 MINAPR 29
Comments
Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma

Revised USP Chapter 797 (Part 3): Practical Approaches to Attaining Compliance

In Part 3 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about practical approaches for attaining compliance.

17 MIN2019 JUL 23
Comments
Revised USP Chapter 797 (Part 3): Practical Approaches to Attaining Compliance

Revised USP Chapter 797 (Part 2): Getting Your Facility Ready

In Part 2 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about changes that may be needed to get your facility ready.

20 MIN2019 JUL 23
Comments
Revised USP Chapter 797 (Part 2): Getting Your Facility Ready

Revised USP Chapter <797> (Part 1): Overview of Changes

In Part 1 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about key changes to note.

15 MIN2019 JUL 23
Comments
Revised USP Chapter <797> (Part 1): Overview of Changes

Integrating Gene Therapies into Pharmacy Practice

William Zellmer talks with John Petrich and Michael Storey about gene therapies and considerations for integrating them into pharmacy practice.

19 MIN2019 JAN 19
Comments
Integrating Gene Therapies into Pharmacy Practice

Insourcing Sterile i.v. Compounding Service: Emory University Hospital Midtown Profile

Angela Cassano talks with Ryan Forrey about insourcing compounded sterile products and how he addressed the challenges faced at Emory University Hospital Midtown.

27 MIN2017 APR 27
Comments
Insourcing Sterile i.v. Compounding Service: Emory University Hospital Midtown Profile

Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2)

Part 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabetes and the roles for pharmacists in individualizing insulin therapy. This installment is produced by A S H P Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department ...

26 MIN2017 FEB 28
Comments
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2)

Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2)

Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor, Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Joshua Neumiller, PharmD, CDE, FASCP Vice Chair and Associate Professor, Department of Pharmacotherapy Washington State Unive...

21 MIN2017 FEB 28
Comments
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2)

Biosimilars: Current Status in the European Union and United States (Part 1 of 2)

In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical Pharmacy University of Michigan College of Pharmacy President, Hospital and Health System Services Visante, Inc. Ann Arbor, Michigan C.E. Credits: This activity is not eligible for continuing education credits.

18 MIN2016 FEB 6
Comments
Biosimilars: Current Status in the European Union and United States (Part 1 of 2)
hmly
Welcome to Himalaya Premium